Cell Sorting Market

Cell Sorting Market Size (2022 to 2027)

The global cell sorting market is estimated to be worth USD 325.7 Million by 2027 from USD 231.49 Million in 2022, growing at a CAGR of 7.07% during the forecast period.

Cell Sorting Market Share Insights:

• Based on technology, the FACS-based droplet sorting segment dominated the cell sorting market in 2021.

• Based on application, the research segment captured a major global cell sorting market share in 2021.

• Based on end-user, the research institutes segment had the leading global cell sorting market share in 2021.

• North America was the most dominating regional market worldwide in 2021.

• The European region is expected to be worth USD 76.62 million by 2027.

• The Asia-Pacific region is anticipated to grow at a CAGR of 9.5% from 2022 to 2027.

Cell sorting is an essential tool broadly used in many components of biomedical, biological research, and clinical therapy. Cell sorting is used to separate specific cells from the heterogeneous cell mixture. Cell sorting reagent allows the isolation of any cell from any species. Flow cytometers assist these systems in separating varied types of cells based on their properties. Fluorescence-Activated Cell Sorting (FACS) and cell imaging microscopes are the methods used by this system to characterize the various particles or cells. Cell-sorting system helps in rare cells' precise isolation from a sample of heterogeneous cells, thereby enabling the downstream study of cells for varied applications. Cell-sorting system has several applications, from malignancy genomics, primary research, and clinical trials to forensic and non-invasive prenatal diagnosis.

MARKET DRIVERS:

Increasing funding and investments for developing technologically advanced cell sorters, technological advancements in cell sorters, and the growing adoption of cell sorting techniques in research activities propel the growth of the global cell sorting market.

The growth of the global cell sorting market is further driven by factors such as increasing pharmaceutical and biotechnology industries, the launch of specific reagents for specific applications, and the rising prevalence of HIV/AIDS and cancer. 1.9 million people are expected to be diagnosed with cancer in 2022, a prediction by the American Cancer Society. According to World Health Organization (WHO), an estimated 10 million died of cancer, which is also one in six deaths in 2020. In addition, fast-growing wing markets, including Asia-Pacific and Latin America, the emergence of microfluidics technology for cell sorting, and continuous growth in the research of stem cells are expected to offer new opportunities for organizations operating in the global cell sorting market.

Across Asia-Pacific, countries such as India and China, with emerging economies, are increasingly becoming preferred destinations for companies in cell sorting due to the rise in common diseases like cancer. As a result, funds are being poured into the latest research and development activities. In addition, Asia-Pacific is also experiencing high commonness in chronic diseases such as HIV and other applicable disorders that produce plenty of opportunities for growth in the global cell sorting market.

MARKET RESTRAINTS:

However, factors such as the high equipment cost and lack of awareness & technical knowledge regarding cell sorters are hindering the growth of the global cell sorting market.

Impact of COVID-19 on the global cell sorting market:

COVID-19 is a newly discovered novel coronavirus that causes an infectious disease. The disease has spread to almost every nation since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Cell sorting is a technique that involves separating cells from an organism and sorting them according to their type. Differences in cell size, surface protein expression, and morphology are used to distinguish the cells. Cell sorting is a complicated mechanism of analysis in which fluorophore-conjugated antibodies are isolated from one another based on which fluorophore they were stained with. The increasing incidence of lung, colorectal, breast, and liver cancers, among others, is expected to speed up cancer cell-sorting procedures. In addition, many laboratories are interested in the production and clinical trials of the SARSCoV2 vaccine. By sorting unfixed antigen-specific lymphocytes, laboratories will be responsible for a significant part of this initiative. As a result, it's important and timely that we understand risk assessment and proven infectious cell sorting procedures.  As a result, the cell sorting market had moderate growth during this pandemic.

REPORT COVERAGE:

This research report on the global cell sorting market has been segmented and sub-segmented based on the technology, product, application, end-user, and region.

Cell Sorting Market - By Technology:

• FACS-based Droplet Sorting
• MACS
• Microfluidics

Based on the technology, the fluorescence-based droplet cell sorting segment had the largest share of the global cell sorting market in 2021. FACS offers fast, objective, and quantitative recording accuracy and complete applications, which surge the segment growth globally. On the other hand, high costs associated with fluorescence-based droplet cell sorting are expected to inhibit the segment's growth rate during the forecast period.

The microfluidics segment is projected to showcase the fastest CAGR due to new products invention, which are driving high demand. In addition, the cost-effective nature of microfluidics is further boosting the adoption of this technology and resulting in the segment's growth.

Cell Sorting Market - By Product:

• Cell Sorters
• Reagents
• Consumables

Based on the product, the cell sorters segment captured the leading share in the global cell sorting market in 2021 and is expected to dominate the market throughout the forecast period. The invention of new instruments has improved the sorting procedure, leading to quick results.

The reagents and consumables segment had a considerable share in the global cell sorting market in 2021 and is expected to hold a strong foothold during the forecast period. Reagents and consumables are used in various applications, one of the key factors propelling the segment’s growth.

Cell Sorting Market - By Application:

• Research
• Clinical

Based on the application, the research segment is expected to grow at a promising CAGR due to increasing cancer research. The clinical application segment is anticipated to have a lucrative growth rate as a frequent increase in diseases like HIV and cancer. In addition, the increasing adoption of cellular analysis in research activities is primarily driving the segment’s growth.

The clinical application is anticipated to do well during the forecast period. The increasing patient poor suffering from various diseases worldwide fuels the segment’s growth.

Cell Sorting Market - By End-User:

• Research Institutes
• Biopharma Companies
• Medical Schools

The research institutes segment accounts for the largest share of the cell sorting market throughout the forecast period based on the end-user. The segment is driven by the growing number of research activities in cellular analysis, increasing cell-based therapies and applications, and growing investments and funds in cancer and stem cell research to propel the segment's growth globally.

Medical schools are estimated to have considerable growth in the cell sorting market due to increasing collaborations, mergers, and acquisitions between pharma and biotech companies, which leads to growth in several research activities.

Cell Sorting Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Regionally, the cell sorting market in North America is estimated to have the largest share during the forecast period, followed by Europe and Asia-Pacific. Huge investments in pharmaceutical and biotechnology companies and the growing obtainment of cell sorting towards cancer research are expected to drive the growth of the North American market. The U.S. cell sorting market is expected to lead the North American market due to the growing incidence rate of cancer, which drives this region's growth. Nearly 133 million Americans, which means more than 40% of the population, are affected by chronic diseases.

The cell sorting market in Europe was the second largest region, followed by North America in the global market in 2019 due to upgraded research infrastructures, significant healthcare expenditure, and increasing research funds from the government and other organizations.

The cell sorting market in Asia-Pacific is projected to have the highest growth potential by 2025. Emerging markets in developing countries like India and China have become attractive places for companies developing and marketing cell sorters. Factors contributing to the growth of the Asia-Pacific cell sorting technologies market include increased funding for cancer research activities and increasing support from the government to reinforce the biotechnology industry.

The cell sorting market in Latin America is contributed by growing demand for cell therapies, high capability of stem cells and growth in cancer research and advancements in technology, and increased chronic diseases in the cell sorting market during the analysis period. Brazil is one of the largest leading countries in this region, followed by Mexico, Argentina, and Columbia.

The cell sorting market in Middle East & Africa is anticipated to have the least and slow growth rate in the cell sorting market of this region.

KEY MARKET PARTICIPANTS:

Some of the notable participants leading the global cell sorting market covered in this report are Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sony Biotechnology, Inc. (U.S.), Sysmex Partec GmbH (Japan), Cytonome/ST, LLC (U.S.), On-Chip Biotechnologies Co., Ltd. (Japan), and Union Biometrica, Inc. (U.S.)

RECENT MARKET HAPPENINGS:

• In April 2019, Miltenyi Biotec introduced a new platform for fully automated and high-content imaging at the AACR ANNUAL MEETING 2019 in ATLANTA, the MACSima Imaging Platform.  
• In June 2019, Beckman Coulter Life Sciences announced its acquisition of Cytobank, a software platform for multi-parametric single-cell data analysis, software as a service company based in Santa Clara, California. 
• In March 2019, the reconstruction of kidney tubules derived from human kidney adult stem cells in microfluidic chips. The tubules show cilia at the luminal side and ion transporters at the blood side. 
• In January 2019, STEMCELL Technologies launched mTeSR Plus, an enhanced version of mTeSR 1, a widely accepted feeder-free human pluripotent stem cell maintenance medium. It has undergone beta testing with several Stem Cell Coredinates group members. 
• In March 2018, Terumo BCT, a U.S.-based global leader in blood component and cellular technologies, selected services and consulting firm Capgemini to set up two global innovation and development (I&D) centers in India. 
• In October 2018, UniCAR- Therapy Bio-Medicine technology chose Terumo BCT and its cell expansion devices to implement automation in its cell therapy manufacturing process for chimeric antigen receptor CAR T-cell therapies.